サポート>ブログ>VHH抗体(VHH Antibodies)

VHH抗体(VHH Antibodies)

Biointron 2024-01-20
VHH.jpg
Image credit: DOI: 10.1177/1535370219881129

Antibodies are essential tools in modern medicine and research, but not all antibodies are the same. VHH antibodies, also known as single-domain antibodies or nanobodies, are a type of antibody that offers several advantages over conventional antibodies. 

VHH antibodies are derived from the immune system of camelids, which produce antibodies that are much smaller than those produced by humans or mice. VHH antibodies consist of a single domain, or variable region, that is capable of binding to specific antigens. This makes them ideal for a wide range of applications, including diagnostic tests, therapeutics, and research tools. 

One key advantage of VHH antibodies is their small size. This allows them to penetrate tissues more effectively than larger antibodies, making them useful for targeting diseases that are difficult to reach with conventional therapies. Additionally, VHH antibodies are highly stable and can withstand harsh conditions, such as high temperatures or acidic environments, which makes them useful for a range of diagnostic and therapeutic applications. 

At Biointron, we specialize in the production of high-quality recombinant VHH antibodies for research and diagnostic purposes. Our team of experts uses state-of-the-art technologies to generate VHH antibodies that are highly specific and sensitive to their target antigens. Whether you need custom VHH antibody production or off-the-shelf options, we have the expertise to deliver the right solution for your needs. 

To learn more about our VHH antibody services, visit our website or contact us today. 

Subscribe to our ブログ
Recommended Articles
2026 Networking Lunch Recap: “At the Table: Antibody Discovery”

Biointron’s Networking Lunch (At the Table: Antibody Discovery) was held at Cata……

Mar 17, 2026
International Women’s Day: Recognizing Women Driving Innovation in Biologics

Each year on International Women’s Day, the global community recognizes the achi……

Mar 08, 2026
AACR IO – Los Angeles: Highlights and Event Recap

​AACR Immuno-Oncology Conference (AACR IO) 2026 was held in Los Angeles from Feb……

Feb 23, 2026
Challenges in Bispecific Antibody Expression

Bispecific antibodies (bsAbs) are engineered molecules capable of simultaneously……

Feb 18, 2026

お客様の利便性を向上させるためにクッキーを使用しています。詳しくは プライバシーポリシー をご覧ください。